Back to News
Market Impact: 0.15
Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
The Law Offices of Howard G. Smith announced that investors with substantial losses may seek to lead a securities-fraud class action against Unicycive Therapeutics, Inc. The brief notice provides no details on the allegations, claimed losses, or case status.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
UNCY-0.80
More News
- Tesla drops 'Full Self-Driving' brand name in Europe after regulator pushback
- Trump created a committee to dig into the Fed's Lisa Cook. What is it and what comes next?
- Tesla’s ‘Full Self-Driving’ Becomes ‘Assisted Driving’ in Europe
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Humana Stock Jumps on Raised Medicare Advantage Ratings